Neurotech Pharmaceuticals

Neurotech Pharmaceuticals

 

Neurotech Pharmaceuticals is a biotechnology company developing sight-saving therapies for retinal diseases. Opthalmic scientists, engineers, technologists, and clinicians all work together to invent new treatments against blindness. Neurotech''s patented core technology platform, Encapsulated Cell Technology (ECT), is a genetically engineered implant that enables the continuous delivery of protein drugs directly to the vitreous of the eye. The living ECT implants continuously treat diseased retinas for over 2 years - superior to conventional approaches that require monthly eye injections.